source
- FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with NovoEli Lilly’s once-weekly basal insulin shot Onswik has been approved by the FDA for patients with type 2 diabetes. Lilly has touted Onswik as a longer-acting alternative to daily basal insulin injec…Endpoints · 1mo ago↗ source
- Backed by NVIDIA, Basecamp bags $140M to advance AI-designed drugsBasecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from investors, including Isomorphic Labs and Enveda.BioSpace · 1mo ago↗ source
- Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride AmpulesBD is correcting convenience kits and procedural trays containing recalled Huons Co. sodium chloride ampules